RenovoRx Reports Strong Q2 2025 Revenue Growth and Receives Positive Independent Committee Recommendation to Continue Phase III TIGeR-PaC Trial RenovoRx, Inc. (Nasdaq: RNXT), a clinical-stage life sciences company pioneering targeted…
Omeros Corporation Reports Second Quarter 2025 Financial Results, Advances Narsoplimab Regulatory Reviews, and Strengthens Balance Sheet Omeros Corporation (Nasdaq: OMER), a biopharmaceutical company dedicated to developing novel therapeutics for serious…
ScaleReady Awards $300,000 G-Rex® Grant to Gates Institute’s Translational Sciences Laboratory to Advance Modular CAR T-Cell Manufacturing ScaleReady, a joint venture formed by Wilson Wolf Manufacturing, Bio-Techne Corporation, and CellReady,…
Scholar Rock Announces Landmark Lancet Neurology Publication of Pivotal Phase 3 SAPPHIRE Trial Results for Apitegromab in Spinal Muscular Atrophy Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company dedicated to…
Nu-Tek BioSciences to Showcase 100% Animal-Free Peptones and Yeast Extracts at BPI East 2025, Driving the Future of Sustainable Cell Culture and Fermentation In an era where biopharmaceutical manufacturers are…
Cybin Announces Major Clinical and Regulatory Milestones Alongside First Quarter Fiscal Year 2026 Financial Results Cybin Inc. (NYSE American: CYBN) (Cboe Canada: CYBN), a clinical-stage breakthrough neuropsychiatry company focused on…
Alto Neuroscience Appoints Raymond Sanchez, M.D., to Board of Directors, Strengthening Leadership as Company Advances Late-Stage Precision Psychiatry Pipeline Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO), a clinical-stage biopharmaceutical company pioneering…
Innoviva Specialty Therapeutics Earns Dual Nominations for 2025 Prix Galien USA Best Pharmaceutical Product Award for ZEVTERA® and XACDURO® Innoviva Specialty Therapeutics, a wholly owned subsidiary of Innoviva, Inc. (NASDAQ:…
Pilatus Biosciences Launches Clinical Trial Collaboration with Roche to Advance First-in-Human Evaluation of PLT012 in Liver Cancer Pilatus Biosciences, Inc., a biotechnology company focused on developing innovative metabolic checkpoint immunotherapies…
Infinity Bio Partners with Austrian Institute of Technology to Deliver Antibody Reactome Profiling Across Europe Infinity Bio, Inc., a pioneering leader in advanced immune system analysis, has announced a strategic…
Response Pharmaceuticals Announces Positive Phase 2 Results for RDX-002 in Post-GLP-1 Obesity Management Response Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing next-generation therapies for weight management and metabolic…
TriSalus Life Sciences Announces Strong Q2 2025 Results, Affirms Full-Year Outlook, and Advances Strategic Focus on Liver-Directed Therapies TriSalus Life Sciences, Inc. (Nasdaq: TLSI), an oncology company pioneering innovative delivery…
